NeoGenomics Inc. Announces Partnership with Lilly for Lung Cancer Sponsored Testing Program Utilizing the NeoTYPE(R) DNA and RNA Assay

25.04.2022 - FT. MYERS, FL / ACCESSWIRE / April 25, 2022 / NeoGenomics, Inc. (NASDAQ:NEO), a leading provider of cancer-focused genetic testing services and global oncology contract research services, announced today that they are partnering with Eli Lilly and ... Seite 1

Related Keywords

Derek Lyle ,Anthony Nino Sireci ,Clinical Division Of Neogenomics ,Diagnostics Development ,Lilly Lung Cancer Sponsored Testing Program ,Chief Medical Officer ,Clinical Division ,Generation Sequencing ,Vice President ,Clinical Biomarkers ,Loxo Oncology ,Neogenomics ,